A retrospective study assessing real world experience with Ocrelizumab in patients with primary progressive multiple sclerosis
Latest Information Update: 16 Dec 2021
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 16 Dec 2021 New trial record